Journalism of Courage
Covovax
COVOVAX NEWS
Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults
April 03, 2023 5:22 pm
The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults
January 18, 2023 5:41 pm
The letter was written by Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), they said. National Technical Advisory Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter.
Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dose
December 22, 2022 5:09 pm
Covax has been approved by the European Medicines Agency for conditional market authorisation, and for emergency-use listing by the WHO.
Delighted to receive approval for Covovax children in 7+ age group: Adar Poonawalla
June 30, 2022 3:57 am
The DCGI had granted permission for conducting phase 3 clinical trial of Covovax as a booster dose in adults who had been fully vaccinated with either Covaxin or Covishield.
Only 500 shots of SII's Covovax administered in Delhi in two months
June 27, 2022 10:47 am
Around 80 per cent of the children in the age group of 12 to 14 years and more between the ages of 15 and 17 years have received the first dose of their vaccine.
Few takers for Covovax, say two Delhi hospitals administering vaccine
May 30, 2022 6:50 pm
There are 160 slots available daily for Covovax shots together in Makkar and Virmani hospitals, according to CoWIN. Each dose of the protein subunit vaccine will cost Rs 386 (including charges of the hospital and GST).
Private hospitals in Delhi start administering Covovax shots, priced at Rs 386
May 30, 2022 12:08 pm
Covovax is the second Covid-19 vaccine manufactured by the SII along with the most commonly used Covishield.
NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group
April 30, 2022 7:56 am
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 age group, subject to certain conditions, on March 9.
Thailand gets 2 lakh doses of India-made Covovax
April 22, 2022 1:00 am
The doses were handed over to Thai Deputy Prime Minister Anutin Charnvirakul in Bangkok by Indian Ambassador Suchitra Durai, Australian envoy Allan McKinnon, Japan’s Nashida Kazuya and US Charge d’Affaires James Wayman.
Drug regulator grants emergency use authorisation to Covovax for 12-17 age group
March 09, 2022 8:05 pm
It is the fourth vaccine to receive the regulator's nod for use among those below 18 years.
Advertisement
Best of Express
EntertainmentBollywood actor worked as a carpenter, delivered helmet to John Abraham as delivery boy; is studying psychology after delivering Rs 100 cr hits at BO
TrendingIndian techie’s parents’ reaction to his first salary wins internet’s hearts: ‘This is a lot of money’
Trending'What’s your skincare routine?’: Harleen Deol’s question makes PM Modi 'blush' during a meeting with Women’s World Cup winners
Advertisement
Advertisement